Orphazyme A/S (0CUM.L)

0.9860 -0.2660 (-21.25%) As of 10:07AM BST. Market open.

Orphazyme A/S

Visionhouse
Lyskær 8A
Herlev 2730
Denmark

https://www.orphazyme.com

Sector(s): 
Industry: 
Full-time employees: 1

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jakob Færch Bendtsen	CEO & Director	N/A	N/A	1978

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in DKK.

Description

Orphazyme A/S does not have significant operations. Previously, it was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is based in Herlev, Denmark.

Corporate governance

Orphazyme A/S’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.